Betahistine Viatris 8 mg tabl.

Pays: Belgique

Langue: anglais

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingrédients actifs:

Betahistine Dihydrochloride 8 mg

Disponible depuis:

Viatris GX BV-SRL

Code ATC:

N07CA01

DCI (Dénomination commune internationale):

Betahistine Dihydrochloride

Dosage:

8 mg

forme pharmaceutique:

Tablet

Composition:

Betahistine Dihydrochloride 8 mg

Mode d'administration:

Oral use

Domaine thérapeutique:

Betahistine

Descriptif du produit:

CTI code: 213403-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213403-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213403-05 - Pack size: 84 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213403-04 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213403-10 - Pack size: 180 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213403-01 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213403-11 - Pack size: 120 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213403-07 - Pack size: 100 - Commercialisation status: YES - FMD code: 05099151910196 - CNK code: 1588623 - Delivery mode: Medical prescription; CTI code: 213403-06 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213403-09 - Pack size: 168 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 213403-08 - Pack size: 112 - Commercialisation status: NO - Delivery mode: Medical prescription

Statut de autorisation:

Commercialised: Yes

Date de l'autorisation:

2000-06-05